Evogene (EVGN) Shares Outstanding (Weighted Average) (2016 - 2025)

Evogene (EVGN) has disclosed Shares Outstanding (Weighted Average) for 10 consecutive years, with $8.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 2301.71% to $8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.7 million through Dec 2025, up 2301.71% year-over-year, with the annual reading at $8.7 million for FY2025, 2301.71% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $8.7 million in Q4 2025 for Evogene, up from $363000.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $40.4 million in Q4 2021 to a low of $363000.0 in Q4 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $11.6 million across 5 years, with a median of $4.6 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 92.09% in 2024 and later soared 2301.71% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $40.4 million in 2021, then plummeted by 89.76% to $4.1 million in 2022, then increased by 10.81% to $4.6 million in 2023, then tumbled by 92.09% to $363000.0 in 2024, then skyrocketed by 2301.71% to $8.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for EVGN at $8.7 million in Q4 2025, $363000.0 in Q4 2024, and $4.6 million in Q4 2023.